Natco Pharma reported a sharp decline in fourth-quarter revenue and operating profit, while margins contracted significantly year-on-year. The company’s shares fell over 9% following the earnings announcement.
Natco Pharma reported a sharp decline in fourth-quarter revenue and operating profit, while margins contracted significantly year-on-year. The company’s shares fell over 9% following the earnings announcement.